Montag & Caldwell LLC Sells 40,632 Shares of Sherwin-Williams Co (NYSE:SHW)

Montag & Caldwell LLC lessened its position in Sherwin-Williams Co (NYSE:SHW) by 29.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 99,317 shares of the specialty chemicals company’s stock after selling 40,632 shares during the quarter. Sherwin-Williams accounts for 2.3% of Montag & Caldwell LLC’s portfolio, making the stock its 21st largest position. Montag & Caldwell LLC owned about 0.11% of Sherwin-Williams worth $45,516,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Investors Research Corp bought a new stake in shares of Sherwin-Williams in the 1st quarter worth about $25,000. Thor Advisors LLC bought a new stake in shares of Sherwin-Williams in the 1st quarter worth about $25,000. Hexavest Inc. bought a new stake in shares of Sherwin-Williams in the 2nd quarter worth about $27,000. Penserra Capital Management LLC bought a new stake in Sherwin-Williams during the 1st quarter valued at about $28,000. Finally, Ibex Wealth Advisors bought a new stake in Sherwin-Williams during the 2nd quarter valued at about $40,000. Hedge funds and other institutional investors own 76.05% of the company’s stock.

Shares of NYSE:SHW traded up $3.90 during trading hours on Thursday, hitting $519.16. The company’s stock had a trading volume of 5,273 shares, compared to its average volume of 650,873. Sherwin-Williams Co has a 52 week low of $355.28 and a 52 week high of $527.00. The company has a debt-to-equity ratio of 2.29, a current ratio of 0.80 and a quick ratio of 0.50. The firm has a market capitalization of $47.61 billion, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 2.03 and a beta of 1.28. The company’s fifty day moving average is $484.85.

Sherwin-Williams (NYSE:SHW) last posted its quarterly earnings results on Tuesday, July 23rd. The specialty chemicals company reported $6.57 EPS for the quarter, beating the consensus estimate of $6.35 by $0.22. Sherwin-Williams had a net margin of 6.61% and a return on equity of 48.92%. The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.94 billion. During the same quarter in the previous year, the business posted $5.73 EPS. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. Equities research analysts forecast that Sherwin-Williams Co will post 21.1 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 6th. Stockholders of record on Friday, August 16th will be given a $1.13 dividend. This represents a $4.52 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Thursday, August 15th. Sherwin-Williams’s payout ratio is currently 24.39%.

In other news, Chairman John G. Morikis sold 16,260 shares of Sherwin-Williams stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $471.26, for a total value of $7,662,687.60. Following the transaction, the chairman now owns 112,276 shares of the company’s stock, valued at approximately $52,911,187.76. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Susan J. Kropf sold 1,000 shares of Sherwin-Williams stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $478.11, for a total transaction of $478,110.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 31,608 shares of company stock worth $15,329,391. Insiders own 0.50% of the company’s stock.

A number of equities research analysts recently weighed in on SHW shares. Northcoast Research reiterated a “neutral” rating on shares of Sherwin-Williams in a report on Monday, July 29th. Wolfe Research lowered shares of Sherwin-Williams from an “outperform” rating to a “peer perform” rating in a report on Thursday, April 25th. Zacks Investment Research upgraded shares of Sherwin-Williams from a “sell” rating to a “hold” rating and set a $526.00 price objective for the company in a report on Thursday, July 25th. JPMorgan Chase & Co. lifted their price objective on shares of Sherwin-Williams from $435.00 to $490.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Finally, Morgan Stanley set a $600.00 price objective on shares of Sherwin-Williams and gave the company a “buy” rating in a report on Monday. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $518.63.

About Sherwin-Williams

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors and do-it-yourself homeowners.

Further Reading: What is the strike price in options trading?

Institutional Ownership by Quarter for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with's FREE daily email newsletter.